Last reviewed · How we verify

Staccato Loxapine

Alexza Pharmaceuticals, Inc. · Phase 2 active Small molecule

Staccato Loxapine is a Small molecule drug developed by Alexza Pharmaceuticals, Inc.. It is currently in Phase 2 development. Also known as: ADASUVE.

At a glance

Generic nameStaccato Loxapine
Also known asADASUVE
SponsorAlexza Pharmaceuticals, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Staccato Loxapine

What is Staccato Loxapine?

Staccato Loxapine is a Small molecule drug developed by Alexza Pharmaceuticals, Inc..

Who makes Staccato Loxapine?

Staccato Loxapine is developed by Alexza Pharmaceuticals, Inc. (see full Alexza Pharmaceuticals, Inc. pipeline at /company/alexza-pharmaceuticals-inc).

Is Staccato Loxapine also known as anything else?

Staccato Loxapine is also known as ADASUVE.

What development phase is Staccato Loxapine in?

Staccato Loxapine is in Phase 2.

Related